Klebsiella oxytoca: an opportunistic bacterial pathogen that poses challenges for treatment and vaccine development

Gabriela Guerrera Soares1, Maria Carolina Francalassi Sarcinelli1, Marcelo Silva Folhas Damas1,2

  • 1Departamento de Genética e Evolução, Universidade Federal de São Carlos, São Carlos, Brazil.

Future Microbiology
|February 13, 2026
PubMed

Insights

Klebsiella oxytoca is a major cause of illness and death. This review explores antibiotic resistance, vaccine development challenges, and new tools like AI for creating effective Klebsiella oxytoca vaccines.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccinology

Background:

  • Klebsiella oxytoca is a significant opportunistic pathogen contributing to global morbidity and mortality.
  • Limited understanding of its genomic diversity, virulence factors, and immune evasion mechanisms hinders effective control.
  • Antibiotic resistance in K. oxytoca presents a major therapeutic challenge.

Purpose of the Study:

  • To review current knowledge on antibiotic resistance in K. oxytoca.
  • To discuss the potential of bacterial vaccines in mitigating antimicrobial resistance and infection rates.
  • To examine challenges in traditional vaccine development and explore novel approaches.

Main Methods:

  • Literature review of K. oxytoca research.
  • Analysis of antibiotic resistance patterns.
  • Evaluation of traditional and emerging vaccine development strategies.
  • Exploration of subtractive proteomics, reverse vaccinology, AI, and machine learning.

Main Results:

  • K. oxytoca exhibits significant antibiotic resistance, complicating treatment.
  • Traditional vaccine development faces hurdles like animal testing, high costs, and long timelines.
  • Emerging technologies show promise for accelerating vaccine candidate identification.

Conclusions:

  • Further research is essential to overcome K. oxytoca's challenges.
  • Innovative therapeutic and preventive strategies, particularly effective vaccines, are urgently needed.
  • Novel approaches like AI and machine learning could revolutionize vaccine development for K. oxytoca.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
51.9K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Sustainable Development01:43

Sustainable Development

As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.2K
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
60.2K
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
41.3K